Education
About Us
Working with TipRanks
Follow Us
Roquefort Investments PLC (GB:ROQ)
LSE:ROQ
RESEARCH TOOLSreports
ROQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range1.32p - 6.78p
Previous CloseN/A
Volume352.01K
Average Volume (3M)843.82K
Market Cap
£2.56M
Enterprise ValueN/A
Total Cash (Recent Filing)£595.66K
Total Debt (Recent Filing)£609.70K
Price to Earnings (P/E)―
Beta-0.01
Next Earnings
Sep 25, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding154,977,480
10 Day Avg. Volume1,366,188
30 Day Avg. Volume843,817
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Roquefort Investments PLC News
PremiumCompany Announcements
Roquefort Therapeutics Extends Convertible Loan Notes Maturity
PremiumCompany Announcements
Roquefort Therapeutics Updates on Strategic Transactions and Future Direction
PremiumCompany Announcements
Roquefort Therapeutics Reports 2024 Results and Strategic Developments
PremiumCompany Announcements
Roquefort Therapeutics Announces Leadership Transition Amid Strategic Sales
PremiumCompany Announcements
Roquefort Therapeutics Announces Proposed Sale of Oncogeni LtdPremiumCompany Announcements
Roquefort Therapeutics Advances Sale of Lyramid to Pleiades Pharma
PremiumCompany Announcements
Roquefort Therapeutics Leaders Increase Stake in CompanyOptions Prices
Currently, No data available
---
Ownership Overview
13.72% Insiders
―
Mutual Funds
― Other Institutional Investors
86.28% Public Companies and
Individual Investors
ROQ FAQ
What was Roquefort Investments PLC’s price range in the past 12 months?
Roquefort Investments PLC lowest share price was 1.32p and its highest was 6.78p in the past 12 months.
What is Roquefort Investments PLC’s market cap?
Roquefort Investments PLC’s market cap is £2.56M.
When is Roquefort Investments PLC’s upcoming earnings report date?
Roquefort Investments PLC’s upcoming earnings report date is Sep 25, 2025 which is in 121 days.
How were Roquefort Investments PLC’s earnings last quarter?
Roquefort Investments PLC released its earnings results on Apr 30, 2025. The company reported -0.003p earnings per share for the quarter, missing the consensus estimate of N/A by -0.003p.
Is Roquefort Investments PLC overvalued?
According to Wall Street analysts Roquefort Investments PLC’s price is currently Overvalued.
Does Roquefort Investments PLC pay dividends?
Roquefort Investments PLC does not currently pay dividends.
What is Roquefort Investments PLC’s EPS estimate?
Roquefort Investments PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Roquefort Investments PLC have?
Roquefort Investments PLC has 154,977,480 shares outstanding.
What happened to Roquefort Investments PLC’s price movement after its last earnings report?
Roquefort Investments PLC reported an EPS of -0.003p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.811%.
Which hedge fund is a major shareholder of Roquefort Investments PLC?
Currently, no hedge funds are holding shares in GB:ROQ
Company Description
Roquefort Investments PLC
Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.